Episodes
26
Latest episode
May 2025
Language
EN
Join Crossroads by Alantra, where our global experts discuss the global trends and what they mean for your investment portfolio or business. Alantra is an international financial services firm providing investment banking and alternative asset management services to corporations, family-owned companies, and institutional investors.. Find out more > Alantra | Possibility is in the ascent
In this episode, Frederic Laurier and Pierre-Alain Rikkers are joined by David Snow, Chairman & CEO of Cedar Gate Technologies. They explore how the transition from fee-for-service to value-based care is accelerating, and why accurate data, payer-provider alignment, and end-to-end solutions are essential for sustainable success.
Elad Walach, CEO of Aidoc, joins Frederic Laurier and Darius Kuddo at Alantra to discuss the core pain points addressed and success created at Aidoc in facilitating the adoption of clinical AI. Elad covers the importance of workflow and change management, proving ROI in a fee for service reimbursement environment, the emergence of transformative foundation image models, ecosystem dynamics, and the roles we could expect from big tech and other large corporates in the space moving forward.
Don Levy, Managing Director in Transaction Advisory Services at Kroll, joins David Waldstein, Managing Director, Industrials, Aerospace & Defense at Alantra, to discuss common challenges in M&A processes in the Industrials sector, emphasizing key issues such as time, financial projections, and sell-side due diligence.
Gadi Lachman, Founder and CEO of TriNetX, joins Frederic Laurier, Managing Director at Alantra, to delve into the essential role Real-World Data (RWD) plays in revolutionizing the healthcare industry. From unraveling the essence of RWD to illustrating its tangible impact through real-life examples, Gadi showcases TriNetX’s profound influence on pharmaceutical companies. TriNetX has continuously expanded its data repository while optimizing its customers’ clinical trial success, from protocol design to site selection, to patient recruitment.
In this episode, Deepinder Singh, founder and CEO of 75F, joins Aakash Bhasin, Managing Director at Alantra to delve into the transformative impact of AI on the building automation sector. Deepinder explains how AI-based machine learning makes it possible to optimize automation in complex environments like commercial buildings, contributes to decarbonization goals, and mitigates climate change impacts. He also discusses why large language models are helping democratize technology by making expert knowledge accessible globally.
AJ joins Frederic Laurier and Pierre-Alain Rikkers at Alantra to discuss the lack of transparency and complexity in drug pricing and the oligopolistic PBM industry structure, perpetuating a convoluted reimbursement system. He argues that PBMs exploit the system’s opacity for profit through “casino economics,“ with practices like spread pricing and clawbacks that financially penalize pharmacies, creating inefficiencies and inequities.
In this episode, Mark Frank, CEO and Co-founder of SonderMind, joins Frederic Laurier, Managing Director at Alantra, to dive into the complexities of the mental health industry. The episode sheds light on SonderMind’s innovative approach of enhancing therapist efficiency and explores how Mark’s diverse background and personal journey have significantly influenced the development of SonderMind. Additionally, the dialogue encompasses the various technological and regulatory hurdles that are currently confronting the mental health sector, emphasizing the necessity for strategic solutions.
Touching the hottest topic at the moment - Artificial Intelligence - Alfred Whitehead, EVP of Applied Sciences at Klick Consulting, joins Rusty Ray at Alantra to unfold applications in drug commercialization, particularly OTC, and its impact on personalization in marketing and product development.
In this episode, Rick Froehlich, CEO of ClearDATA, joins Frederic and Michael to discuss the challenges healthcare organizations face in adopting cloud technology, focusing on security concerns surrounding PHI data. The reluctance of providers to migrate due to budget constraints and limited resources creates hurdles for Managed Service Providers. We also highlight ClearDATA’s emergence as a leader in healthcare cybersecurity amid rising threats, offering tailored solutions and a robust CyberHealth Platform.
Paul Wardle led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor and TUMS. Following up on our last episode on Rx-to-OTC Switches, Paul sheds lights on ACNU - the FDA's proposed rule on non-prescription drug products with additional conditions for non-prescriptive use. This is the FDA's 12-year effort in the works, aiming to empower consumers, foster stakeholder collaboration, and redefine access based on individual characteristics.
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
